Lopresti ML, Bian JJ, Sakr BJ, Strenger RS, et al. Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in
HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG)
study. Breast Cancer Res Treat 2021 Jun 4. pii: 10.1007/s10549-021-06266.
PMID: 34086171